Canada is quickly advancing efforts to respond to the current COVID-19 pandemic in Canada and around the globe. As part of our response, we wanted to provide you with information on the Operating Grant : COVID-19 May 2020 Rapid Research Funding Opportunity launched by the Canadian Institutes of Health Research (CIHR) and our partners.
COVID-19 Rapid Research Funding Opportunity
Canada recognizes the importance of international cooperation in health research, particularly to address the global COVID-19 pandemic. As such the call invites applicants located in Canada to build on existing multi-site/multi-jurisdictional international networks, infrastructures and relationships with partners, including in low- and middle-income countries (LMICS), in order to leverage efforts and increase timeliness, efficiency, and impact of the response. For example, this can include the inclusion of Canadian sites for trials being led internationally to better enable harmonized data collection, sharing of data, quasi-experimental and observational studies, and rapid large-scale evaluation of impact.
Funding will support clinical trials, observational studies, implementation science or other relevant study designs to scale-up promising existing projects, reorient current research, or initiate new rapid response research to address COVID-19 in the identified research areas that include understanding the safety, efficacy, effectiveness, ethics, and implementation of:
- vaccines, diagnostics, or therapeutics;
- clinical management and health system interventions;
- social, policy, and public health responses, and related indirect consequences.
Call budget: approximately $107.9MApplication Deadline: May 11, 2020
Partner Linkage Tool
To facilitate collaboration and enable a rapid and timely research response, CIHR has established a tool whereby researchers and/or research groups in Canada and internationally can signal their interest in collaborating on this opportunity. To learn more visit: linkage tool.
Nominated Principle Applicants (responsible for coordinating the financial and administrative aspects of the grant) must be based at an eligible institution in Canada. However, researchers based outside of Canada may collaborate on applications as either principal applicants, co-applicants or collaborators if they meet the relevant definitions in the CIHR Application Administration Guide, as well as the specific eligibility criteria outlined in the funding opportunity.For all inquiries about this call, please contact the CIHR Contact Centre at EHTRF-FRNMS@cihr-irsc.gc.ca.
Other Funding Opportunities launched by Canadian partners
- $40 million for the Canadian COVID Genomics Network (CanCOGeN), led by Genome Canada, to coordinate a COVID-19 genome sequencing effort across Canada. This research will help track the virus and its different strains, providing valuable information to public health authorities and policymakers as they set measures to control the pandemic.The results of this work will be accessible to researchers globally to enable additional research, including Canadian vaccine development efforts.
- $23 million for the Vaccine and Infectious Disease Organization ̶ International Vaccine Centre
(VIDO-InterVac), a highly specialized health research institute in Saskatoon, to accelerate development of a vaccine against COVID-19. This funding will support pre-clinical testing and clinical trials of COVID-19 vaccine candidates,which are essential to ensuring that vaccines are effective and safe for human use.
- $29 million for the National Research Council (NRC) to begin the second phase of critical upgrades to its Human Health Therapeutics facility in Montréal. Building on ongoing work to ready the facility for the production of vaccines for clinical trials, this funding will support operations to maintain the facility, as well as provide infrastructure to prepare vials for individual doses as soon as a vaccine becomes available.
- ISED providing $600 million to the Strategic Innovation Fund COVID-19 stream to deliver direct support to Canadian companies for large-scale projects.
- Canadian Data Monitoring Initiative -- $10M over 1 year to coordinate and share pandemic-related data to enhance Canada’s response to COVID-19, as recommended by Chief Science Advisor.
- Canadian COVID-19 Sero-surveillance Consortium -- $300M over 2 years for national survey to inform national immunization strategies.
- Canadian Immunization Research Network (CIRN) -- $10.3M over 2 years and $5M ongoing to CIRN and eight partner networks to conduct vaccine related research and clinical trials.